Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Marcello Maida, Fabio Salvatore Macaluso, Gianluca Ianiro, Francesca Mangiola, Emanuele Sinagra, Georgina Hold, Carlo Maida, Giovanni Cammarota, Antonio Gasbarrini & Giuseppe Scarpulla. (2017) Screening of colorectal cancer: present and future. Expert Review of Anticancer Therapy 17:12, pages 1131-1146.
Read now
Read now
Colin J Rees & Roisin Bevan. (2013) The National Health Service Bowel Cancer Screening Program: the early years. Expert Review of Gastroenterology & Hepatology 7:5, pages 421-437.
Read now
Read now
Kjetil Søreide, Bjørn S Nedrebø, Andreas Reite, Kenneth Thorsen & Hartwig Kørner. (2009) Endoscopy, morphology, morphometry and molecular markers: predicting cancer risk in colorectal adenoma. Expert Review of Molecular Diagnostics 9:2, pages 125-137.
Read now
Read now
Matti Hakama, Geir Hoff, Ole Kronborg & Lars Påhlman. (2005) Screening for colorectal cancer. Acta Oncologica 44:5, pages 425-439.
Read now
Read now
G. Hoff. (2004) CRC screening: review of the evidence and suggestions on when and how to move on from randomized trials to screening programmes. Scandinavian Journal of Gastroenterology 39:2, pages 99-103.
Read now
Read now
Articles from other publishers (103)
Henriette C. Jodal, Paulina Wieszczy-Szczepanik, Dagmar Klotz, Magnhild Herfindal, Ishita Barua, Petter Tag, Lise M. Helsingen, Erle Refsum, Øyvind Holme, Hans-Olov Adami, Michael Bretthauer, Mette Kalager & Magnus Løberg. (2023) A Comparison of Risk Classification Systems of Colorectal Adenomas: A Case-Cohort Study. Gastroenterology 165:2, pages 483-491.e7.
Crossref
Crossref
Mona Berthelsen, Paula Berstad, Kristin R. Randel, Geir Hoff, Erik Natvig, Øyvind Holme & Edoardo Botteri. (2022) The impact of driving time on participation in colorectal cancer screening with sigmoidoscopy and faecal immunochemical blood test. Cancer Epidemiology 80, pages 102244.
Crossref
Crossref
Saurabh Chandan, Antonio FacciorussoPradeep YarraShahab R. KhanDaryl RamaiBabu P. MohanLena L. KassabMohammad BilalAasma Shaukat. (2022) Colonoscopy-Related Adverse Events in Patients With Abnormal Stool-Based Tests: A Systematic Review of Literature and Meta-analysis of Outcomes. American Journal of Gastroenterology 117:3, pages 381-393.
Crossref
Crossref
Henriette C. Jodal, Dagmar Klotz, Magnhild Herfindal, Ishita Barua, Petter Tag, Lise M. Helsingen, Erle Refsum, Øyvind Holme, Hans‐Olov Adami, Michael Bretthauer, Mette Kalager & Magnus Løberg. (2021) Long‐term colorectal cancer incidence and mortality after adenoma removal in women and men. Alimentary Pharmacology & Therapeutics 55:4, pages 412-421.
Crossref
Crossref
Jennifer S. Lin, Leslie A. Perdue, Nora B. Henrikson, Sarah I. Bean & Paula R. Blasi. (2021) Screening for Colorectal Cancer. JAMA 325:19, pages 1978.
Crossref
Crossref
Kristin R. Randel, Anna L. Schult, Edoardo Botteri, Geir Hoff, Michael Bretthauer, Giske Ursin, Erik Natvig, Paula Berstad, Anita Jørgensen, Per Kristian Sandvei, Marie Ek Olsen, Svein Oskar Frigstad, Ole Darre-Næss, Espen R. Norvard, Nils Bolstad, Hartwig Kørner, Arne Wibe, Knut-Arne Wensaas, Thomas de Lange & Øyvind Holme. (2021) Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial. Gastroenterology 160:4, pages 1085-1096.e5.
Crossref
Crossref
Colin J Rees, Andrew Brand, Wee Sing Ngu, Clive Stokes, Zoe Hoare, Nicola Totton, Pradeep Bhandari, Linda Sharp, Alexandra Bastable, Matthew D Rutter, Ajay Mark Verma, Thomas J Lee & Martin Walls. (2020) BowelScope: Accuracy of Detection Using Endocuff Optimisation of Mucosal Abnormalities (the B-ADENOMA Study): a multicentre, randomised controlled flexible sigmoidoscopy trial. Gut 69:11, pages 1959-1965.
Crossref
Crossref
Matthew D Rutter, James East, Colin J Rees, Neil Cripps, James Docherty, Sunil Dolwani, Philip V Kaye, Kevin J Monahan, Marco R Novelli, Andrew Plumb, Brian P Saunders, Siwan Thomas-Gibson, Damian J M Tolan, Sophie Whyte, Stewart Bonnington, Alison Scope, Ruth Wong, Barbara Hibbert, John Marsh, Billie Moores, Amanda Cross & Linda Sharp. (2020) British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 69:2, pages 201-223.
Crossref
Crossref
Vasileios Panteris, Nikolaos Vasilakis, Maria Demonakou, Eleni Kornarou, Eftyxios Ktenas, Emanuella Rapti, George Spithakis, Konstantina Katopodi, Maria Horti, Stefani Vgenopoulou, John Triantafyllidis, Apostolos Papalois & Panagiotis Karantanos. (2019) Alarming endoscopic data in young and older asymptomatic people: Results of an open access, unlimited age colonoscopic screening for colorectal cancer. Molecular and Clinical Oncology.
Crossref
Crossref
Henriette C Jodal, Lise M Helsingen, Joseph C Anderson, Lyubov Lytvyn, Per Olav Vandvik & Louise Emilsson. (2019) Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis. BMJ Open 9:10, pages e032773.
Crossref
Crossref
Roisin Bevan, Roger G Blanks, Claire Nickerson, Brian P Saunders, John Stebbing, Richard Tighe, Andrew M Veitch, William Garrett & Colin J Rees. (2019) Factors affecting adenoma detection rate in a national flexible sigmoidoscopy screening programme: a retrospective analysis. The Lancet Gastroenterology & Hepatology 4:3, pages 239-247.
Crossref
Crossref
Trine B. Rounge, Roger Meisal, Jan Inge Nordby, Ole Herman Ambur, Thomas de Lange & Geir Hoff. (2018) Evaluating gut microbiota profiles from archived fecal samples. BMC Gastroenterology 18:1.
Crossref
Crossref
Markus D. Knudsen, Anette Hjartåker, Marie K.E. Olsen, Geir Hoff, Thomas de Lange, Tomm Bernklev & Paula Berstad. (2018) Changes in health behavior 1 year after testing negative at a colorectal cancer screening: a randomized-controlled study. European Journal of Cancer Prevention 27:4, pages 316-322.
Crossref
Crossref
Mechteld C. de Jong, Rianne C.J. Beckers, Victor van Woerden, Julie M.L. Sijmons, Marc H.A. Bemelmans, Ronald M. van Dam & Cornelis H.C. Dejong. (2018) The liver-first approach for synchronous colorectal liver metastases: more than a decade of experience in a single centre. HPB 20:7, pages 631-640.
Crossref
Crossref
Øyvind HolmeMagnus LøbergMette KalagerMichael BretthauerMiguel A. HernánEline AasTor J. EideEva SkovlundJon LekvenJörn SchneedeKjell Magne TveitMorten VatnGiske UrsinGeir Hoff. (2018) Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men. Annals of Internal Medicine 168:11, pages 775-782.
Crossref
Crossref
Tobias Niedermaier, Korbinian Weigl, Michael Hoffmeister & Hermann Brenner. (2018) Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies. European Journal of Epidemiology 33:5, pages 473-484.
Crossref
Crossref
Roisin Bevan & Matthew D Rutter. (2018) Colorectal Cancer Screening—Who, How, and When?. Clinical Endoscopy 51:1, pages 37-49.
Crossref
Crossref
Håvard Thøgersen, Bjørn Møller, Trude Eid Robsahm, Stein Aaserud, Ronnie Babigumira & Inger Kristin Larsen. (2017) Comparison of cancer stage distribution in the immigrant and host populations of Norway, 1990-2014. International Journal of Cancer 141:1, pages 52-61.
Crossref
Crossref
N.C.A. Vermeer, H.S. Snijders, F.A. Holman, G.J. Liefers, E. Bastiaannet, C.J.H. van de Velde & K.C.M.J. Peeters. (2017) Colorectal cancer screening: Systematic review of screen-related morbidity and mortality. Cancer Treatment Reviews 54, pages 87-98.
Crossref
Crossref
S. V. Kashin, N. V. Nekhaykova, D. V. Zavyalov, N. S. Vidyaeva & A. N. Belova. (2017) The colorectal cancer screening: the current global situation and the main standards for the quality of screening colonoscopy recommended by the European Society of Gastrointestinal Endoscopy (ESGE). Dokazatel'naya gastroenterologiya 6:4, pages 32.
Crossref
Crossref
Colin J Rees, Siwan Thomas Gibson, Matt D Rutter, Phil Baragwanath, Rupert Pullan, Mark Feeney & Neil Haslam. (2016) UK key performance indicators and quality assurance standards for colonoscopy. Gut 65:12, pages 1923-1929.
Crossref
Crossref
Colin J Rees, Roisin Bevan, Katharina Zimmermann-Fraedrich, Matthew D Rutter, Douglas Rex, Evelien Dekker, Thierry Ponchon, Michael Bretthauer, Jaroslaw Regula, Brian Saunders, Cesare Hassan, Michael J Bourke & Thomas Rösch. (2016) Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut 65:12, pages 2045-2060.
Crossref
Crossref
Donna Fitzpatrick-Lewis, Muhammad Usman Ali, Rachel Warren, Meghan Kenny, Diana Sherifali & Parminder Raina. (2016) Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis. Clinical Colorectal Cancer 15:4, pages 298-313.
Crossref
Crossref
. (2016) UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 4:5_suppl, pages A157-A720.
Crossref
Crossref
Jon A. LorentzenKrzysztof GrzybPaula M. De AngelisGeir HoffTor J. EidePer Arne Andresen. (2016) Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study. Clinical Medicine Insights: Pathology 9, pages CPath.S40143.
Crossref
Crossref
Jill Tinmouth, Emily T. Vella, Nancy N. Baxter, Catherine Dubé, Michael Gould, Amanda Hey, Nofisat Ismaila, Bronwen R. McCurdy & Lawrence Paszat. (2016) Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Canadian Journal of Gastroenterology and Hepatology 2016, pages 1-18.
Crossref
Crossref
Paola Armaroli, Patricia Villain, Eero Suonio, Maribel Almonte, Ahti Anttila, Wendy S. Atkin, Peter B. Dean, Harry J. de Koning, Lena Dillner, Rolando Herrero, Ernst J. Kuipers, Iris Lansdorp-Vogelaar, Silvia Minozzi, Eugenio Paci, Jaroslaw Regula, Sven Törnberg & Nereo Segnan. (2015) European Code against Cancer, 4th Edition: Cancer screening. Cancer Epidemiology 39, pages S139-S152.
Crossref
Crossref
Paula Berstad, Magnus Løberg, Inger Kristin Larsen, Mette Kalager, Øyvind Holme, Edoardo Botteri, Michael Bretthauer & Geir Hoff. (2015) Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial. Gut 64:8, pages 1268-1276.
Crossref
Crossref
Øyvind Holme, Michael Bretthauer, Tor J Eide, Else Marit Løberg, Krzysztof Grzyb, Magnus Løberg, Mette Kalager, Hans-Olov Adami, Øystein Kjellevold & Geir Hoff. (2015) Long-term risk of colorectal cancer in individuals with serrated polyps. Gut 64:6, pages 929-936.
Crossref
Crossref
Inés Castro, Pamela Estevez, Joaquín Cubiella, Vicent Hernandez, Carmen González-Mao, Concepción Rivera, Felipe Iglesias, Lucía Cid, Santiago Soto, Luisa de-Castro, Pablo Vega, Jose Antonio Hermo, Ramiro Macenlle, Alfonso Martínez, Estela Cid, Inés Gil, Mikel Larzabal, Luis Bujanda & Antoni Castells. (2014) Diagnostic Performance of Fecal Immunochemical Test and Sigmoidoscopy for Advanced Right-Sided Colorectal Neoplasms. Digestive Diseases and Sciences 60:5, pages 1424-1432.
Crossref
Crossref
Maurice B Loughrey & Neil A Shepherd. (2015) The pathology of bowel cancer screening. Histopathology 66:1, pages 66-77.
Crossref
Crossref
Andrew J Gawron, William K Thompson, Rajesh N Keswani, Luke V Rasmussen & Abel N Kho. (2014) Anatomic and Advanced Adenoma Detection Rates as Quality Metrics Determined via Natural Language Processing. American Journal of Gastroenterology 109:12, pages 1844-1849.
Crossref
Crossref
Saurabh Mukewar, Meagan Costedio, Xianrui Wu, Navkaran Bajaj, Rocio Lopez, Aaron Brzezinski & Bo Shen. (2014) Severe Adverse Outcomes of Endoscopic Perforations in Patients with and Without IBD. Inflammatory Bowel Diseases 20:11, pages 2056-2066.
Crossref
Crossref
Leonie van Dam & Michael Bretthauer. (2014) Ethical issues in colorectal cancer screening. Best Practice & Research Clinical Gastroenterology 28:2, pages 315-326.
Crossref
Crossref
Andrew J. Gawron & Rena Yadlapati. (2013) Disparities in Endoscopy Use for Colorectal Cancer Screening in the United States. Digestive Diseases and Sciences 59:3, pages 530-537.
Crossref
Crossref
Pedro J. Tárraga LópezJuan Solera AlberoJosé Antonio Rodríguez-Montes. (2014) Primary and Secondary Prevention of Colorectal Cancer. Clinical Medicine Insights: Gastroenterology 7, pages CGast.S14039.
Crossref
Crossref
Jean-Luc Bulliard, Montse Garcia, Johannes Blom, Carlo Senore, Verna Mai & Carrie Klabunde. (2014) Sorting out measures and definitions of screening participation to improve comparability: The example of colorectal cancer. European Journal of Cancer 50:2, pages 434-446.
Crossref
Crossref
Linda Sharp, Lesley Tilson, Sophie Whyte, Alan O Ceilleachair, Cathal Walsh, Cara Usher, Paul Tappenden, James Chilcott, Anthony Staines, Michael Barry & Harry Comber. (2013) Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland. BMC Health Services Research 13:1.
Crossref
Crossref
Øyvind Holme, Michael Bretthauer, Atle Fretheim, Jan Odgaard-Jensen & Geir Hoff. (2013) Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database of Systematic Reviews 2014:3.
Crossref
Crossref
Andrew J. Gawron, Barbara Jung, Angela J. Fought, Babs H. Waldman & Neehar D. Parikh. (2013) A Colorectal Cancer Screening Program in an Underserved, Ethnically Diverse Population in Chicago, IL. Journal of Community Health 38:4, pages 603-608.
Crossref
Crossref
S. E. Steigen, V. Isaksen, A. Skjæveland & B. Vonen. (2013) Adenomas with Adenocarcinoma: A Study Evaluating the Risk Of Residual Cancer And Lymph Node Metastasis. Scandinavian Journal of Surgery 102:2, pages 90-95.
Crossref
Crossref
C Littlejohn, S Hilton, G J Macfarlane & P Phull. (2012) Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. British Journal of Surgery 99:11, pages 1488-1500.
Crossref
Crossref
Adeyinka O. Laiyemo, Chyke Doubeni, Paul F. Pinsky, V. Paul Doria-Rose, Andrew K. SandersonIIII, Robert Bresalier, Joel Weissfeld, Robert E. Schoen, Pamela M. Marcus, Philip C. Prorok & Christine D. Berg. (2012) Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. Cancer Epidemiology 36:4, pages 395-399.
Crossref
Crossref
Paul Rozen, Irena Liphshitz & Micha Barchana. (2012) Changing Epidemiology of Colorectal Cancer Makes Screening Sigmoidoscopy Less Useful for Identifying Carriers of Colorectal Neoplasms. Digestive Diseases and Sciences 57:8, pages 2203-2212.
Crossref
Crossref
Lieke Hol, Ernst J. Kuipers, Marjolein van Ballegooijen, Anneke J. van Vuuren, Jaqueline C.I.Y. Reijerink, Dik J.F. Habbema & Monique E. van Leerdam. (2011) Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme. International Journal of Cancer 130:9, pages 2096-2102.
Crossref
Crossref
J. L. Weissfeld, R. E. Schoen, P. F. Pinsky, R. S. Bresalier, V. P. Doria-Rose, A. O. Laiyemo, T. Church, L. A. Yokochi, S. Yurgalevitch, J. Rathmell, G. L. Andriole, S. Buys, E. D. Crawford, M. Fouad, C. Isaacs, L. Lamerato, D. Reding, P. C. Prorok & C. D. Berg. (2012) Flexible Sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Added Yield from a Second Screening Examination. JNCI Journal of the National Cancer Institute 104:4, pages 280-289.
Crossref
Crossref
L Sharp, L Tilson, S Whyte, A O'Ceilleachair, C Walsh, C Usher, P Tappenden, J Chilcott, A Staines, M Barry & H Comber. (2012) Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy. British Journal of Cancer 106:5, pages 805-816.
Crossref
Crossref
Tsutomu Saraya, Hiroaki Ikematsu, Kuang I. Fu, Chihiro Tsunoda, Yusuke Yoda, Yasuhiro Oono, Takashi Kojima, Tomonori Yano, Takahiro Horimatsu, Yasushi Sano & Kazuhiro Kaneko. (2011) Evaluation of complications related to therapeutic colonoscopy using the bipolar snare. Surgical Endoscopy 26:2, pages 533-540.
Crossref
Crossref
Jorja D Warren, Wei Xiong, Ashley M Bunker, Cecily P Vaughn, Larissa V Furtado, William L Roberts, John C Fang, Wade S Samowitz & Karen A Heichman. (2011) Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Medicine 9:1.
Crossref
Crossref
Jette Bornholdt, Stine Friis, Sine Godiksen, Steen S Poulsen, Eric Santoni-Rugiu, Hanne C Bisgaard, Inger MB Lothe, Tone Ikdahl, Kjell M Tveit, Egil Johnson, Elin H Kure & Lotte K Vogel. (2011) The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer 11:1.
Crossref
Crossref
N. Segnan, P. Armaroli, L. Bonelli, M. Risio, S. Sciallero, M. Zappa, B. Andreoni, A. Arrigoni, L. Bisanti, C. Casella, C. Crosta, F. Falcini, F. Ferrero, A. Giacomin, O. Giuliani, A. Santarelli, C. B. Visioli, R. Zanetti, W. S. Atkin & C. Senore. (2011) Once-Only Sigmoidoscopy in Colorectal Cancer Screening: Follow-up Findings of the Italian Randomized Controlled Trial--SCORE. JNCI Journal of the National Cancer Institute 103:17, pages 1310-1322.
Crossref
Crossref
Stefan de Vogel, Jörn Schneede, Per Magne Ueland, Stein Emil Vollset, Klaus Meyer, Åse Fredriksen, Øivind Midttun, Tone Bjørge, Ellen Kampman, Michael Bretthauer & Geir Hoff. (2011) Biomarkers Related to One-Carbon Metabolism as Potential Risk Factors for Distal Colorectal Adenomas. Cancer Epidemiology, Biomarkers & Prevention 20:8, pages 1726-1735.
Crossref
Crossref
Adeyinka O. Laiyemo, Chyke Doubeni, Andrew K. SandersonIIII, Paul F. Pinsky, Dilhana S. Badurdeen, V. Paul Doria-Rose, Pamela M. Marcus, Robert E. Schoen, Elaine Lanza, Arthur Schatzkin & Amanda J. Cross. (2011) Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointestinal Endoscopy 74:2, pages 253-261.
Crossref
Crossref
Perry J. Pickhardt, Nathan A. Durick, B. Dustin Pooler & Cesare Hassan. (2011) Left-sided Polyps Detected at Screening CT Colonography: Do We Need Complete Optical Colonoscopy for Further Evaluation?. Radiology 259:2, pages 429-434.
Crossref
Crossref
Daniele Regge, Gabriella Iussich & Andrea Laghi. 2011. Atlas of Virtual Colonoscopy. Atlas of Virtual Colonoscopy
75
78
.
Theodore R Levin & Linda Rabeneck. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
311
323
.
M. von Euler-Chelpin, K. Brasso & E. Lynge. (2009) Determinants of participation in colorectal cancer screening with faecal occult blood testing. Journal of Public Health 32:3, pages 395-405.
Crossref
Crossref
Michael Bretthauer. (2010) Evidence for colorectal cancer screening. Best Practice & Research Clinical Gastroenterology 24:4, pages 417-425.
Crossref
Crossref
Geir Hoff. (2010) Colorectal cancer screening in an expanding panorama of screening programmes. Best Practice & Research Clinical Gastroenterology 24:4, pages 521-527.
Crossref
Crossref
Daniele Regge, Giovanni Galatola, Cristiana Laudi & Gabriella Iussich. (2010) Role of CT colonography in screening programs. Imaging in Medicine 2:2, pages 181-194.
Crossref
Crossref
Sanna A. Mulder, Eva M. van Soest, Jeanne P. Dieleman, Leo G.M. van Rossum, Rob J.Th. Ouwendijk, Monique E. van Leerdam & Ernst J. Kuipers. (2010) Exposure to colorectal examinations before a colorectal cancer diagnosis: a case–control study. European Journal of Gastroenterology & Hepatology 22:4, pages 437-443.
Crossref
Crossref
DAVID H. KIM & PERRY J. PICKHARDT. 2010. CT Colonography: Principles and Practice of Virtual Colonoscopy. CT Colonography: Principles and Practice of Virtual Colonoscopy
157
172
.
Joanna Selzer-Plon, Jette Bornholdt, Stine Friis, Hanne C Bisgaard, Inger MB Lothe, Kjell M Tveit, Elin H Kure, Ulla Vogel & Lotte K Vogel. (2009) Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer 9:1.
Crossref
Crossref
Hanne Skovbjerg, Dorit Anthonsen, Inger MB Lothe, Kjell M Tveit, Elin H Kure & Lotte K Vogel. (2009) Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer 9:1.
Crossref
Crossref
B. Denis, I. Gendre, F. Aman, F. Ribstein, P. Maurin & P. Perrin. (2009) Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: A French population-based controlled study (Wintzenheim trial). European Journal of Cancer 45:18, pages 3282-3290.
Crossref
Crossref
James E. Allison. (2009) The Imperative of Equal Funding for Studies That Evaluate Any of the Evidence-Based, Guideline-Recommended Colorectal Cancer Screening Tests. Clinical Gastroenterology and Hepatology 7:12, pages 1269-1271.
Crossref
Crossref
Emily Power, Anne Miles, Christian von Wagner, Katie Robb & Jane Wardle. (2009) Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Future Oncology 5:9, pages 1371-1388.
Crossref
Crossref
J. B. M. J. Jansen, R. J. F. Laheij & L. G. M. van Rossum. (2009) Bevolkingsonderzoek naar darmkanker. Bijblijven 25:7, pages 34-44.
Crossref
Crossref
Kjetil Søreide, Bjørn S. Nedrebø, Jens-Christian Knapp, Tom B. Glomsaker, Jon Arne Søreide & Hartwig Kørner. (2009) Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: Potential implications for the surgical oncologist. Surgical Oncology 18:1, pages 31-50.
Crossref
Crossref
R. Peravali, K. Kandiah, A. Surah, P. Murria, P. Taniere & S. Radley. (2009) Retrospective analysis of pre- and peri-operative imaging in confirmed proximal colonic cancers - possible implications for screening flexible sigmoidoscopy. Colorectal Disease 11:2, pages 146-149.
Crossref
Crossref
Bernard Levin, David A. Lieberman, Beth McFarland, Kimberly S. Andrews, Durado Brooks, John Bond, Chiranjeev Dash, Francis M. Giardiello, Seth Glick, David Johnson, C. Daniel Johnson, Theodore R. Levin, Perry J. Pickhardt, Douglas K. Rex, Robert A. Smith, Alan Thorson & Sidney J. Winawer. (2008) Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134:5, pages 1570-1595.
Crossref
Crossref
Victoria S. Benson, Julietta Patnick, Anna K. Davies, Marion R. Nadel, Robert A. Smith & Wendy S. Atkin. (2007) Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. International Journal of Cancer 122:6, pages 1357-1367.
Crossref
Crossref
Camilla F Skjelbred, Mona Sæbø, Anette Hjartåker, Tom Grotmol, Inger-Lise Hansteen, Kjell M Tveit, Geir Hoff & Elin H Kure. (2007) Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer 7:1.
Crossref
Crossref
Anders Lorentzen, Lotte K Vogel, Rikke H Lewinsky, Mona Sæbø, Camilla F Skjelbred, Sine Godiksen, Geir Hoff, Kjell M Tveit, Inger Marie Bowitz Lothe, Tone Ikdahl, Elin H Kure & Cathy Mitchelmore. (2007) Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer 7:1.
Crossref
Crossref
E.M. Tweedle, P.S. Rooney & A.J.M. Watson. (2007) Screening for Rectal Cancer – Will it Improve Cure Rates?. Clinical Oncology 19:9, pages 639-648.
Crossref
Crossref
Gerda Engholm, Anne Mette T. Kejs, David H. Brewster, Maria Gaard, Lars Holmberg, Roger Hartley, Robert Iddenden, Henrik Møller, Risto Sankila, Catherine S. Thomson & Hans H. Storm. (2007) Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. International Journal of Cancer 121:5, pages 1115-1122.
Crossref
Crossref
Øivind Midttun, Steinar Hustad, Jørn Schneede, Stein E Vollset & Per M Ueland. (2007) Plasma vitamin B-6 forms and their relation to transsulfuration metabolites in a large, population-based study. The American Journal of Clinical Nutrition 86:1, pages 131-138.
Crossref
Crossref
Cezary Łoziński & Witold Kycler. (2007) Preliminary assessment of results obtained by the Endoscope Department of Great Poland Cancer Centre, Poznań, in the framework of the Screening Programme for Early Diagnostics of Colon Cancer in years 2004-2005. Reports of Practical Oncology & Radiotherapy 12:4, pages 201-206.
Crossref
Crossref
Nereo Segnan, Carlo Senore, Bruno Andreoni, Alberto Azzoni, Luigi Bisanti, Alessandro Cardelli, Guido Castiglione, Cristiano Crosta, Andrea Ederle, Alberto Fantin, Arnaldo Ferrari, Mario Fracchia, Franco Ferrero, Stefano Gasperoni, Serafino Recchia, Mauro Risio, Tiziana Rubeca, Giorgio Saracco & Marco Zappa. (2007) Comparing Attendance and Detection Rate of Colonoscopy With Sigmoidoscopy and FIT for Colorectal Cancer Screening. Gastroenterology 132:7, pages 2304-2312.
Crossref
Crossref
Pål I. Holm, Steinar Hustad, Per Magne Ueland, Stein Emil Vollset, Tom Grotmol & Jørn Schneede. (2007) Modulation of the Homocysteine-Betaine Relationship by Methylenetetrahydrofolate Reductase 677 C->T Genotypes and B-Vitamin Status in a Large-Scale Epidemiological Study. The Journal of Clinical Endocrinology & Metabolism 92:4, pages 1535-1541.
Crossref
Crossref
Inger K. Larsen, Tom Grotmol, Kari Almendingen & Geir Hoff. (2007) Impact of Colorectal Cancer Screening on Future Lifestyle Choices: A Three-Year Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 5:4, pages 477-483.
Crossref
Crossref
Arnold J. Markowitz. 2007. Colorectal Cancer. Colorectal Cancer
51
68
.
Mona Sæbø, Camilla F Skjelbred, Rebecca Breistein, Inger Marie B Lothe, Per Chr Hagen, Gunter Bock, Inger-Lise Hansteen & Elin H Kure. (2006) Association between cigarette smoking, APCmutations and the risk of developing sporadic colorectal adenomas and carcinomas. BMC Cancer 6:1.
Crossref
Crossref
Camilla Furu Skjelbred, Mona Sæbø, Håkan Wallin, Bjørn Andersen Nexø, Per Christian Hagen, Inger Marie Bowitz Lothe, Steinar Aase, Egil Johnson, Inger-Lise Hansteen, Ulla Vogel & Elin H Kure. (2006) Polymorphisms of the XRCC1, XRCC3 and XPDgenes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer 6:1.
Crossref
Crossref
Mona Sæbø, Camilla Furu Skjelbred, Bjørn Andersen Nexø, Håkan Wallin, Inger-Lise Hansteen, Ulla Vogel & Elin H Kure. (2006) Increased mRNA expression levels of ERCC1, OGG1 and RAIin colorectal adenomas and carcinomas. BMC Cancer 6:1.
Crossref
Crossref
Lotte K Vogel, Mona Sæbø, Camilla F Skjelbred, Kathrine Abell, Esben DK Pedersen, Ulla Vogel & Elin H Kure. (2006) The ratio of Matriptase/HAI-1mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. BMC Cancer 6:1.
Crossref
Crossref
Camilla F Skjelbred, Mona Sæbø, Bjørn A Nexø, Håkan Wallin, Inger-Lise Hansteen, Ulla Vogel & Elin H Kure. (2006) Effects of polymorphisms in ERCC1, ASE-1 and RAIon the risk of colorectal carcinomas and adenomas: a case control study. BMC Cancer 6:1.
Crossref
Crossref
Inger K Larsen, Tom Grotmol, Kari Almendingen & Geir Hoff. (2006) Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterology 6:1.
Crossref
Crossref
Robert Steele. 2006. Colorectal Cancer. Colorectal Cancer
77
101
.
Inger K. Larsen, Tom Grotmol, Kari Almendingen & Geir Hoff. (2006) Lifestyle characteristics among participants in a Norwegian colorectal cancer screening trial. European Journal of Cancer Prevention 15:1, pages 10-19.
Crossref
Crossref
Geir Hoff & Michael Bretthauer. (2006) The Science and Politics of Colorectal Cancer Screening. PLoS Medicine 3:1, pages e36.
Crossref
Crossref
Denis Heresbach, Sylvain Manfrédi, Bernard Branger & Jean-François Bretagne. (2006) Coût-efficacité du dépistage du cancer colorectal. Gastroentérologie Clinique et Biologique 30:1, pages 44-58.
Crossref
Crossref
Jason A. Dominitz & William M. Grady. 2006. Endoscopic Oncology. Endoscopic Oncology
185
196
.
D. Heresbach & J. -F. Bretagne. 2006. Le dépistage du cancer colorectal. Le dépistage du cancer colorectal
57
99
.
Stephen H. Taplin, Sarah Dash, Paula Zeller & Jane Zapka. 2006. Oncology. Oncology
317
340
.
Robert Steele. 2006. Challenges in Colorectal Cancer. Challenges in Colorectal Cancer
14
30
.
Rikke Hansen, Mona Sæbø, Camilla Furu Skjelbred, Bjørn Andersen Nexø, Per Christian Hagen, Günther Bock, Inger Marie Bowitz Lothe, Egil Johnson, Steinar Aase, Inger-Lise Hansteen, Ulla Vogel & Elin H. Kure. (2005) GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Letters 229:1, pages 85-91.
Crossref
Crossref
G Gondal, T Grotmol, B Hofstad, M Bretthauer, T J Eide & G Hoff. (2005) Lifestyle-related risk factors and chemoprevention for colorectal neoplasia: experience from the large-scale NORCCAP screening trial. European Journal of Cancer Prevention 14:4, pages 373-379.
Crossref
Crossref
D. Heresbach, S. Manfredi & J. F. Bretagne. (2005) Stratégies de dépistage du cancer colorectal: endoscopie versus autres modes d’explorationScreening strategies for CRC: endoscopy versus other modalities. Acta Endoscopica 35:4, pages 621-648.
Crossref
Crossref
Joel L. Weissfeld, Robert E. Schoen, Paul F. Pinsky, Robert S. Bresalier, Timothy Church, Susan Yurgalevitch, Joseph H. Austin, Philip C. Prorok & John K. Gohagan. (2005) Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results From the Baseline Screening Examination of a Randomized Trial. JNCI: Journal of the National Cancer Institute 97:13, pages 989-997.
Crossref
Crossref
R. Labianca, G.D. Beretta, S. Mosconi, L. Milesi & M.A. Pessi. (2005) Colorectal cancer: screening. Annals of Oncology 16, pages ii127-ii132.
Crossref
Crossref
M Regev, S-Eisenberg Barzilai, A Figer, J Zidan, HH Fidder & E Friedman. (2005) The I1307K APC mutation in a high-risk clinic setting: a follow-up study. Clinical Genetics 67:4, pages 352-355.
Crossref
Crossref
Paula Berstad, Mona Berthelsen, Kristin R. Randel, Geir Hoff, Erik Natvig, Øyvind Holme & Edoardo Botteri. (2022) The Impact of Driving Time on Participation in Colorectal Cancer Screening with Sigmoidoscopy and Faecal Immunochemical Blood Test. SSRN Electronic Journal.
Crossref
Crossref